Tech Company Financing Transactions
Embera NeuroTherapeutics Funding Round
Embera NeuroTherapeutics closed a $126 thousand funding round on 6/30/2013. Investors included BVM Capital.
Transaction Overview
Company Name
Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$126,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 Boston Post Rd. 210
Sudbury, MA 01776
USA
Sudbury, MA 01776
USA
Phone
Website
Email Address
Not Recorded
Overview
Embera is developing a patent-pending drug combination, EMB-001, that addresses significant unmet needs in smoking cessation and cocaine dependence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Linke
Vice President
Julie Straub
VP - Operations
Gary Connor
VP - Regulatory Affairs
Ann Robbins
Browse more venture capital transactions:
Prev: 6/30/2013: Sittercity venture capital transaction
Next: 6/30/2013: Mercantile Adjustment Bureau venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs